Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Poon

Showing results (351-360 of 401) with videos related to

Pageof 41
Sort By:
Cancer Immunology Research|October 16, 2014
Granulin-epithelin precursor renders hepatocellular carcinoma cells resistant to natural killer cytotoxicityPhyllis F Y Cheung, Chi Wai Yip, Nicholas C L Wong, et al.
Genetics|March 18, 2021
Genetic analysis of Pycr1 and Pycr2 in miceMorgane G Stum, Abigail L D Tadenev, Kevin L Seburn, et al.
Lancet (London, England)|January 29, 1983
Prevention of deterioration of renal and sensory-nerve function by more intensive management of insulin-dependent diabetic patients. A two-year randomised prospective studyR R Holman, T L Dornan, V Mayon-White, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 24, 2014
Survival analysis of high-intensity focused ultrasound therapy vs. transarterial chemoembolization for unresectable hepatocellular carcinomasTan To Cheung, Ronnie T P Poon, Caroline R Jenkins, et al.
Cancer Research|January 18, 2008
The kringle 1 domain of hepatocyte growth factor has antiangiogenic and antitumor cell effects on hepatocellular carcinomaZan Shen, Zhen Fan Yang, Yi Gao, et al.
Annals of Surgical Oncology|April 1, 2010
Enhanced detection of early hepatocellular carcinoma by serum SELDI-TOF proteomic signature combined with alpha-fetoprotein markerLei Chen, David W Y Ho, Nikki P Y Lee, et al.
Molecular Systems Biology|August 27, 2010
microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinomaJulja Burchard, Chunsheng Zhang, Angela M Liu, et al.
Hepatology (Baltimore, Md.)|July 5, 2014
Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trialMasatoshi Kudo, Guohong Han, Richard S Finn, et al.
Journal of Hepatology|September 3, 2013
Post-transplant endothelial progenitor cell mobilization via CXCL10/CXCR3 signaling promotes liver tumor growthChang-Chun Ling, Kevin T P Ng, Yan Shao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2014
A phase II study of the efficacy and safety of the combination therapy of the MEK inhibitor refametinib (BAY 86-9766) plus sorafenib for Asian patients with unresectable hepatocellular carcinomaHo Yeong Lim, Jeong Heo, Hye Jin Choi, et al.
Pageof 41

Showing results (351-360 of 401) with videos related to

Sort By:
Pageof 41
Cancer Immunology Research|October 16, 2014
Granulin-epithelin precursor renders hepatocellular carcinoma cells resistant to natural killer cytotoxicityPhyllis F Y Cheung, Chi Wai Yip, Nicholas C L Wong, et al.
Genetics|March 18, 2021
Genetic analysis of Pycr1 and Pycr2 in miceMorgane G Stum, Abigail L D Tadenev, Kevin L Seburn, et al.
Lancet (London, England)|January 29, 1983
Prevention of deterioration of renal and sensory-nerve function by more intensive management of insulin-dependent diabetic patients. A two-year randomised prospective studyR R Holman, T L Dornan, V Mayon-White, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 24, 2014
Survival analysis of high-intensity focused ultrasound therapy vs. transarterial chemoembolization for unresectable hepatocellular carcinomasTan To Cheung, Ronnie T P Poon, Caroline R Jenkins, et al.
Cancer Research|January 18, 2008
The kringle 1 domain of hepatocyte growth factor has antiangiogenic and antitumor cell effects on hepatocellular carcinomaZan Shen, Zhen Fan Yang, Yi Gao, et al.
Annals of Surgical Oncology|April 1, 2010
Enhanced detection of early hepatocellular carcinoma by serum SELDI-TOF proteomic signature combined with alpha-fetoprotein markerLei Chen, David W Y Ho, Nikki P Y Lee, et al.
Molecular Systems Biology|August 27, 2010
microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinomaJulja Burchard, Chunsheng Zhang, Angela M Liu, et al.
Hepatology (Baltimore, Md.)|July 5, 2014
Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trialMasatoshi Kudo, Guohong Han, Richard S Finn, et al.
Journal of Hepatology|September 3, 2013
Post-transplant endothelial progenitor cell mobilization via CXCL10/CXCR3 signaling promotes liver tumor growthChang-Chun Ling, Kevin T P Ng, Yan Shao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2014
A phase II study of the efficacy and safety of the combination therapy of the MEK inhibitor refametinib (BAY 86-9766) plus sorafenib for Asian patients with unresectable hepatocellular carcinomaHo Yeong Lim, Jeong Heo, Hye Jin Choi, et al.
Pageof 41